A long‐term, open‐label trial of the safety and efficacy of etanercept (Enbrel) in patients with rheumatoid arthritis not treated with other disease‐modifying antirheumatic drugs...

Por Klareskog, L, Gaubitz, M, Rodriguez‐Valverde, V, Malaise, M, Dougados, M, Wajdula, J
Publicado em 2006

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double‐blind comparison

Por Combe, B, Codreanu, C, Fiocco, U, Gaubitz, M, Geusens, P P, Kvien, T K, Pavelka, K, Sambrook, P N, Smolen, J S, Wajdula, J, Fatenejad, S
Publicado em 2006

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised...

Por Combe, B, Codreanu, C, Fiocco, U, Gaubitz, M, Geusens, P P, Kvien, T K, Pavelka, K, Sambrook, P N, Smolen, J S, Khandker, R, Singh, A, Wajdula, J, Fatenejad, S
Publicado em 2008

Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis

Por van der Heijde, D, Da Silva, J C, Dougados, M, Geher, P, van der Horst‐Bruinsma, I, Juanola, X, Olivieri, I, Raeman, F, Settas, L, Sieper, J, Szechinski, J, Walker, D, Boussuge, M‐P, Wajdula, J S, Paolozzi, L, Fatenejad, S
Publicado em 2006